OBJECTIVES: Radiofrequency ablation (RFA) is widely performed for hepatocellular
carcinoma (HCC). However, there has been no report on 10-year outcome of RFA. The …

PURPOSE: To investigate the efficacy of radiofrequency ablation (RFA) for hepatocellular
carcinoma (HCC), and the prognostic factors for post-RFA survival rate. METHODS: From …

Radiofrequency ablation (RFA) of liver cancers can be performed safely using
percutaneous, laparoscopic, or open surgical techniques, and much of the impetus for the …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …

Background Enthusiasm for radiofrequency ablation (RFA) therapy for patients with
unresectable hepatocellular carcinoma (HCC) has increased. The data for recurrence after …

For the treatment of small hepatocellular carcinoma (HCC), radiofrequency ablation (RFA) is
in some centers considered a first-line therapeutic option. However, such a strategy is still …

Objective: To review the current status of radiofrequency ablation (RFA) in the management
of hepatocellular carcinoma (HCC). Summary Background Data: The development of local …

AIM: To investigate the long-term survival and prognostic factors in hepatocellular carcinoma
(HCC) patients undergoing radiofrequency ablation (RFA) as a first-line treatment …

Ablation therapy is one of the best curative treatment options for malignant liver tumors, and
can be an alternative to resection. Radiofrequency ablation (RFA) of primary and secondary …

Background Despite the high complete necrosis rate of radiofrequency ablation (RFA),
tumor recurrence, either local tumor recurrence or new tumor formation, remains a …